Davis Polk advised the placement agents in the transaction.Recursion Pharmaceuticals executed its $150 million private placement of common stock. Morgan Stanley & Co. LLC acted as the lead…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
